Hyperion Defi (HYPD) Change in Accured Expenses (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Change in Accured Expenses of $67117.0 for Q1 2026, up 132.93% year-over-year from $28814.0 in Q1 2025, and up 107.83% quarter-over-quarter from -$857403.0 in Q4 2025.
Hyperion Defi (HYPD) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Change in Accured Expenses for 10 consecutive years, with $67117.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 132.93% year-over-year to $67117.0; the TTM figure through Mar 2026 stood at -$459438.0 (down 181.24% YoY), while the FY2025 annual figure was -$497741.0, down 69.54% from the prior year.
- Change in Accured Expenses climbed to $67117.0 in Q1 2026 per HYPD's latest filing, from -$857403.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.1 million in Q3 2022 and bottomed at -$1.1 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$67966.1 across 5 years, with a median of $67117.0 in 2026.
- On a YoY basis, Change in Accured Expenses climbed as much as 334.42% in 2025 and fell as far as 635.92% in 2025.
- Hyperion Defi's Change in Accured Expenses stood at -$881727.0 in 2022, then jumped by 124.81% to $218795.0 in 2023, then dropped by 26.88% to $159988.0 in 2024, then slumped by 635.92% to -$857403.0 in 2025, then soared by 107.83% to $67117.0 in 2026.
- Business Quant data shows HYPD's Change in Accured Expenses at $67117.0 in Q1 2026, -$857403.0 in Q4 2025, and $282699.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 137,251.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137,251.00 |
| Jun 30, 2026 | 137,251.00 |
| Mar 31, 2026 | 67,117.00 |
| Mar 31, 2026 | 67,117.00 |
| Dec 31, 2025 | -857,403.00 |
| Dec 31, 2025 | -857,403.00 |
| Sep 30, 2025 | 282,699.00 |
| Sep 30, 2025 | 282,699.00 |
| Jun 30, 2025 | 48,149.00 |
| Jun 30, 2025 | 48,149.00 |
| Mar 31, 2025 | 28,814.00 |
| Mar 31, 2025 | 28,814.00 |
| Dec 31, 2024 | 159,988.00 |
| Dec 31, 2024 | 159,988.00 |
| Sep 30, 2024 | 397,300.00 |
| Sep 30, 2024 | 397,300.00 |
| Jun 30, 2024 | -20,540.00 |
| Jun 30, 2024 | -20,540.00 |
| Mar 31, 2024 | -830,327.00 |
| Mar 31, 2024 | -830,327.00 |